ES2595500T3 - Nuevas proteasas que pueden hidrolizar péptidos y proteínas de gluten a un pH ácido, procedentes del actinomiceto Actinoallomurus - Google Patents
Nuevas proteasas que pueden hidrolizar péptidos y proteínas de gluten a un pH ácido, procedentes del actinomiceto Actinoallomurus Download PDFInfo
- Publication number
- ES2595500T3 ES2595500T3 ES12781098.4T ES12781098T ES2595500T3 ES 2595500 T3 ES2595500 T3 ES 2595500T3 ES 12781098 T ES12781098 T ES 12781098T ES 2595500 T3 ES2595500 T3 ES 2595500T3
- Authority
- ES
- Spain
- Prior art keywords
- endopep
- seq
- actinoallomurus
- proteins
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title description 30
- 102000004169 proteins and genes Human genes 0.000 title description 23
- 102000035195 Peptidases Human genes 0.000 title description 22
- 108091005804 Peptidases Proteins 0.000 title description 22
- 235000018102 proteins Nutrition 0.000 title description 21
- 108090000765 processed proteins & peptides Proteins 0.000 title description 19
- 239000004365 Protease Substances 0.000 title description 18
- 102000004196 processed proteins & peptides Human genes 0.000 title description 14
- 241000605656 Actinoallomurus Species 0.000 title description 13
- 108010068370 Glutens Proteins 0.000 title description 8
- 235000021312 gluten Nutrition 0.000 title description 8
- 230000002378 acidificating effect Effects 0.000 title 1
- 241001446247 uncultured actinomycete Species 0.000 title 1
- 102000005593 Endopeptidases Human genes 0.000 abstract description 23
- 108010059378 Endopeptidases Proteins 0.000 abstract description 23
- 239000000203 mixture Substances 0.000 abstract description 15
- 230000002255 enzymatic effect Effects 0.000 abstract description 9
- 239000012634 fragment Substances 0.000 abstract description 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 18
- 150000007523 nucleic acids Chemical group 0.000 description 17
- 102000004190 Enzymes Human genes 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 15
- 229940088598 enzyme Drugs 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 229940066758 endopeptidases Drugs 0.000 description 12
- 108020004707 nucleic acids Proteins 0.000 description 12
- 102000039446 nucleic acids Human genes 0.000 description 12
- 150000001413 amino acids Chemical group 0.000 description 11
- 101710118538 Protease Proteins 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 235000019419 proteases Nutrition 0.000 description 10
- 108010061711 Gliadin Proteins 0.000 description 9
- 102000057297 Pepsin A Human genes 0.000 description 8
- 108090000284 Pepsin A Proteins 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 229940111202 pepsin Drugs 0.000 description 8
- 230000029087 digestion Effects 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 235000015872 dietary supplement Nutrition 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- 238000007792 addition Methods 0.000 description 5
- 230000004071 biological effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000014616 translation Effects 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 235000019833 protease Nutrition 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 208000015943 Coeliac disease Diseases 0.000 description 3
- 102000001708 Protein Isoforms Human genes 0.000 description 3
- 108010029485 Protein Isoforms Proteins 0.000 description 3
- 241000187747 Streptomyces Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000012405 in silico analysis Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 230000002797 proteolythic effect Effects 0.000 description 3
- 241000093906 Actinoallomurus sp. Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001001250 Catenulispora Species 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 241001430082 Ktedonobacter Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 102000035122 glycosylated proteins Human genes 0.000 description 2
- 108091005608 glycosylated proteins Proteins 0.000 description 2
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 235000021056 liquid food Nutrition 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- AUUIARVPJHGTSA-UHFFFAOYSA-N 3-(aminomethyl)chromen-2-one Chemical compound C1=CC=C2OC(=O)C(CN)=CC2=C1 AUUIARVPJHGTSA-UHFFFAOYSA-N 0.000 description 1
- HZWWPUTXBJEENE-UHFFFAOYSA-N 5-amino-2-[[1-[5-amino-2-[[1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid Chemical compound C1CCC(C(=O)NC(CCC(N)=O)C(=O)N2C(CCC2)C(=O)NC(CCC(N)=O)C(O)=O)N1C(=O)C(N)CC1=CC=C(O)C=C1 HZWWPUTXBJEENE-UHFFFAOYSA-N 0.000 description 1
- 241001001804 Actinospica Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000919932 Catenulispora acidiphila Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 102000003779 Dipeptidyl-peptidases and tripeptidyl-peptidases Human genes 0.000 description 1
- 108090000194 Dipeptidyl-peptidases and tripeptidyl-peptidases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001302160 Escherichia coli str. K-12 substr. DH10B Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000610620 Homo sapiens Putative serine protease 29 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001430080 Ktedonobacter racemifer Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 241000187708 Micromonospora Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 101100477212 Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) sed4 gene Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 101710088675 Proline-rich peptide Proteins 0.000 description 1
- 102000056251 Prolyl Oligopeptidases Human genes 0.000 description 1
- 108700015930 Prolyl Oligopeptidases Proteins 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 102100040345 Putative serine protease 29 Human genes 0.000 description 1
- 241001257175 Rugosimonospora Species 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 241000319051 Streptacidiphilus Species 0.000 description 1
- 241000187180 Streptomyces sp. Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000003241 endoproteolytic effect Effects 0.000 description 1
- 210000001842 enterocyte Anatomy 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 108010043175 succinylalanylalanyl-prolyl-phenylalanine-4-methylcoumaryl-7-amide Proteins 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000013819 transposition, DNA-mediated Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/346—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21026—Prolyl oligopeptidase (3.4.21.26), i.e. proline-specific endopeptidase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11425291 | 2011-12-06 | ||
| EP11425291 | 2011-12-06 | ||
| PCT/EP2012/071816 WO2013083338A1 (en) | 2011-12-06 | 2012-11-05 | New proteases able to hydrolyze gluten peptides and proteins at acidic ph, from the actinomycete actinoallomurus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2595500T3 true ES2595500T3 (es) | 2016-12-30 |
Family
ID=47137719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12781098.4T Active ES2595500T3 (es) | 2011-12-06 | 2012-11-05 | Nuevas proteasas que pueden hidrolizar péptidos y proteínas de gluten a un pH ácido, procedentes del actinomiceto Actinoallomurus |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20140356345A1 (enExample) |
| EP (1) | EP2788018B1 (enExample) |
| JP (1) | JP6203743B2 (enExample) |
| CN (1) | CN104039345B (enExample) |
| AU (1) | AU2012348782B2 (enExample) |
| BR (1) | BR112014012100B1 (enExample) |
| CA (1) | CA2852365C (enExample) |
| EA (1) | EA028228B1 (enExample) |
| ES (1) | ES2595500T3 (enExample) |
| IN (1) | IN2014CN04131A (enExample) |
| WO (1) | WO2013083338A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2718434T (lt) | 2011-08-10 | 2018-08-10 | University Of Washington Through Its Center For Commercialization | Kompozicijos ir būdai, skirti celiakijos gydymui |
| US10266815B2 (en) * | 2013-08-14 | 2019-04-23 | University Of Washington Through Its Center For Commercialization | Compositions and methods for treating celiac sprue disease |
| US9867872B2 (en) | 2013-09-05 | 2018-01-16 | Dsm Ip Assets B.V. | Use of an acidic soft drink to enhance the efficacy of a gluten-digesting enzyme |
| WO2015078372A1 (en) * | 2013-11-26 | 2015-06-04 | Novozymes A/S | Milling process |
| CN107105707B (zh) * | 2014-10-24 | 2022-07-22 | 杜邦营养生物科学有限公司 | 脯氨酸耐受性三肽基肽酶及其用途 |
| TN2017000520A1 (en) | 2015-06-08 | 2019-04-12 | Univ California | Compositions and methods for treating celiac sprue disease |
| WO2017139659A1 (en) | 2016-02-11 | 2017-08-17 | Trustees Of Boston University | Rothia subtilisins, s8a family proteases, as therapeutic enzymes for application in gluten-intolerance disorders |
| IT201900012942A1 (it) | 2019-07-25 | 2021-01-25 | Nemysis Ltd | Metodo per la produzione di una composizione enzimatica comprendente una endopeptidasi ricombinante |
| AU2020318422B2 (en) * | 2019-07-25 | 2026-03-19 | Nemysis Limited | Method for the production of an enzymatic composition comprising a recombinant endopeptidase |
| CN111172138B (zh) * | 2020-02-14 | 2022-03-25 | 江南大学 | 一种蛋白水解酶及其在蛋白肽生产中的应用 |
| CA3186744A1 (en) | 2020-06-09 | 2021-12-16 | Dr. Schar S.P.A. | Method to prepare a mixture and food products deriving therefrom |
| IT202100018254A1 (it) | 2021-07-12 | 2023-01-12 | Nemysis Ltd | New systems for producing recombinant proteins/ nuovi sistemi di produzione di proteine ricombinanti |
| CN114438044B (zh) * | 2022-01-14 | 2024-03-29 | 南昌大学 | 一种高效降解麸质蛋白的多酶复合体及其应用 |
| TWI864494B (zh) | 2022-11-17 | 2024-12-01 | 國立中興大學 | 天冬胺酸蛋白酶於水解麩質蛋白之用途、編碼該天冬胺酸蛋白酶之核酸分子、生產該天冬胺酸蛋白酶之方法及其應用 |
| AU2024269012A1 (en) * | 2023-05-11 | 2026-01-08 | Amplifye, Inc. | Wine dehazing methods and compositions |
| WO2025067635A1 (en) * | 2023-09-26 | 2025-04-03 | Amyra Biotech Ag | Pharmaceutical compositions comprising exopeptidases and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3104935B2 (ja) | 1992-05-28 | 2000-10-30 | 株式会社ブリヂストン | 空気入りタイヤ |
| US7320788B2 (en) * | 2002-02-14 | 2008-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for Celiac Sprue |
| AU2003215272B2 (en) * | 2002-02-14 | 2008-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for celiac sprue |
| US7265093B2 (en) * | 2002-05-14 | 2007-09-04 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for Celiac Sprue |
| DK1673457T3 (da) | 2003-08-25 | 2011-09-05 | Funzyme Biotechnologies Sa | Nye svampeproteiner og nukleinsyrer, der koder for disse |
| US8524225B2 (en) | 2003-09-23 | 2013-09-03 | Dsm Ip Assets B.V. | Use of proline specific endoproteases to hydrolyse peptides and proteins |
| NL1027650C1 (nl) | 2004-12-03 | 2006-06-07 | Leonardus Antonius Luttikhold | Transporthulpmiddel voor deuren en panelen. |
| EP1985698A1 (en) * | 2007-04-25 | 2008-10-29 | Nestec S.A. | Peptidases from basidiomycetes |
| EP2515932A2 (en) * | 2009-12-21 | 2012-10-31 | Centre Hospitalier Universitaire Vaudois (CHUV) | Synergic action of a prolyl protease and tripeptidyl proteases |
| EP2531521B1 (en) * | 2010-02-02 | 2017-09-06 | Amano Enzyme USA., Ltd. | Use of proteases for gluten intolerance |
| JP2013523133A (ja) * | 2010-03-30 | 2013-06-17 | アルヴィン ファーマシューティカルズ インコーポレーティッド | グルテンを分解するためのプロテアーゼ |
| JP2011211997A (ja) * | 2010-04-02 | 2011-10-27 | Astellas Pharma Inc | アントラサイクリン化合物を生産する微生物 |
-
2012
- 2012-11-05 JP JP2014545146A patent/JP6203743B2/ja active Active
- 2012-11-05 US US14/356,122 patent/US20140356345A1/en not_active Abandoned
- 2012-11-05 EA EA201491117A patent/EA028228B1/ru not_active IP Right Cessation
- 2012-11-05 CN CN201280060514.5A patent/CN104039345B/zh active Active
- 2012-11-05 ES ES12781098.4T patent/ES2595500T3/es active Active
- 2012-11-05 BR BR112014012100-1A patent/BR112014012100B1/pt active IP Right Grant
- 2012-11-05 CA CA2852365A patent/CA2852365C/en active Active
- 2012-11-05 AU AU2012348782A patent/AU2012348782B2/en active Active
- 2012-11-05 EP EP12781098.4A patent/EP2788018B1/en active Active
- 2012-11-05 WO PCT/EP2012/071816 patent/WO2013083338A1/en not_active Ceased
- 2012-11-05 IN IN4131CHN2014 patent/IN2014CN04131A/en unknown
-
2015
- 2015-11-23 US US14/949,503 patent/US10201593B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20140356345A1 (en) | 2014-12-04 |
| EA028228B1 (ru) | 2017-10-31 |
| IN2014CN04131A (enExample) | 2015-07-17 |
| CA2852365A1 (en) | 2013-06-13 |
| US20160114009A1 (en) | 2016-04-28 |
| CA2852365C (en) | 2021-01-26 |
| US10201593B2 (en) | 2019-02-12 |
| EP2788018B1 (en) | 2016-06-29 |
| AU2012348782A1 (en) | 2014-05-15 |
| HK1198244A1 (en) | 2015-03-20 |
| WO2013083338A1 (en) | 2013-06-13 |
| JP2015500641A (ja) | 2015-01-08 |
| JP6203743B2 (ja) | 2017-09-27 |
| CN104039345B (zh) | 2016-11-09 |
| CN104039345A (zh) | 2014-09-10 |
| BR112014012100A2 (pt) | 2020-10-27 |
| EA201491117A1 (ru) | 2014-09-30 |
| EP2788018A1 (en) | 2014-10-15 |
| BR112014012100B1 (pt) | 2023-04-18 |
| AU2012348782B2 (en) | 2017-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7354734B2 (en) | Fungal proteins and nucleic acids encoding same | |
| JP6203743B2 (ja) | アクチノミセス・アクチノアロムルス（ＡＣＴＩＮＯＭＹＣＥＴＥＡＣＴＩＮＯＡＬＬＯＭＵＲＵＳ）由来の、酸性ｐＨにてグルテンペプチドおよびタンパク質を加水分解できる新規プロテアーゼ | |
| Zaghloul et al. | Biodegradation of chicken feathers waste directed by Bacillus subtilis recombinant cells: Scaling up in a laboratory scale fermentor | |
| CN107384844B (zh) | 一种产磷脂酶d的重组大肠杆菌及其应用 | |
| Alvarez-Sieiro et al. | Generation of food-grade recombinant Lactobacillus casei delivering Myxococcus xanthus prolyl endopeptidase | |
| KR102778820B1 (ko) | 콜라겐을 분해할 수 있는 균주 및 이의 응용 | |
| CN116064492A (zh) | 一种具有高活性的重组酰胺水解酶及其编码基因、重组载体及应用 | |
| KR20080108921A (ko) | 살조활성 단백질분해효소, 이를 코딩하는 유전자 및 이를포함하는 살조제제 | |
| Abidi et al. | MS analysis and molecular characterization of Botrytis cinerea protease Prot-2. Use in bioactive peptides production | |
| WO2021200955A1 (ja) | コラゲナーゼ剤及びその用途 | |
| AU2020318422A1 (en) | Method for the production of an enzymatic composition comprising a recombinant endopeptidase | |
| Zaghloul et al. | Key determinants affecting sheep wool biodegradation directed by a keratinase-producing Bacillus subtilis recombinant strain | |
| CN118159651A (zh) | 用于制造胶原三肽或者分解软骨的酶剂 | |
| US20220162619A1 (en) | Preparation of wheat cysteine protease triticain-alpha produced in soluble form and method of producing same | |
| CN111607579A (zh) | 一种赭曲霉毒素水解酶及其编码基因、重组载体及应用 | |
| CN108070605A (zh) | 多菌灵降解酶CbmA及其编码基因和应用 | |
| KR20110086711A (ko) | 봉입체 형성 단백질의 제조방법 | |
| Tamilmani et al. | Production of an extra cellular feather degrading enzyme by Bacillus licheniformis isolated from poultry farm soil in Namakkal district (Tamilnadu) | |
| KR101123966B1 (ko) | 스트렙토마이세스 그리세우스 변이주 및 이를 이용한 트립신 함량이 높은 프로네이즈 생산방법 | |
| KR101608977B1 (ko) | 서열번호 4를 포함하는 살조활성 단백질분해효소, 이를 코딩하는 유전자 및 이를 포함하는 살조제제 | |
| KR101608979B1 (ko) | 서열번호 5를 포함하는 살조활성 단백질분해효소, 이를 코딩하는 유전자 및 이를 포함하는 살조제제 | |
| KR101617362B1 (ko) | 서열번호 6를 포함하는 살조활성 단백질분해효소, 이를 코딩하는 유전자 및 이를 포함하는 살조제제 | |
| KR20150014425A (ko) | 서열번호 7를 포함하는 살조활성 단백질분해효소, 이를 코딩하는 유전자 및 이를 포함하는 살조제제 | |
| HK1198244B (en) | New proteases able to hydrolyze gluten peptides and proteins at acidic ph, from the actinomycete actinoallomurus |